Drug details

Cabenuva (cabotegravir; rilpivirine extended-release injectable suspension)

type of HIV, Integrase Inhibitors, HIV, NNRTIs

Cabenuva (cabotegravir extended-release injectable suspension; rilpivirine extended-release injectable suspension) is a 2-drug co-packaged product of a human immunodeficiency virus type-1 (HIV-1) integrase strand transfer inhibitor (INSTI) and an HIV-1 non-nucleoside reverse transcriptase inhibitor (NNRTI), indicated as a complete regimen for the treatment of HIV-1 infection in adults to replace the current antiretroviral regimen in those who are virologically suppressed (HIV-1 RNA less than 50 copies per mL) on a stable antiretroviral regimen with no history of treatment failure and with no known or suspected resistance to either cabotegravir or rilpivirine.

The drug is often used to treat HIV .

This drug may have the following side effects:

• hives,
• difficulty breathing,
• swelling of your face, lips, tongue, or throat,
• nausea,
• loss of appetite,
• itching,
• vomiting,
• fever,
• swollen glands,
• skin rash,
• body aches,
• tiredness,
• muscle aches,
• stomach pain (upper right side),
• dark urine, and
• unusual changes in mood or behavior,
• feeling unwell,
• severe weakness,
• unusual bruising,
• yellowing of your skin or eyes (jaundice),
• sores or blisters in your mouth,
• red or puffy eyes,
• thoughts of self-harm or suicide attempts,
• clay-colored stools

The following drugs are related to Cabenuva, either as a replacement or used together:

• Ziagen (abacavir sulfate)
• Epzicom (abacavir sulfate and lamivudine tablets)
• Trizivir (abacavir sulfate, lamivudine, and zidovudine)
• Triumeq (abacavir, dolutegravir, and lamivudine film-coated tablets)
• Apretude (cabotegravir extended-release injectable suspension)
• Aptivus (tipranavir)
• Evotaz (atazanavir and cobicistat tablets for oral administration)
• Reyataz (atazanavir sulfate)
• Atripla (efavirenz, emtricitabine, and tenofovir disoproxil fumarate)
• Biktarvy (bictegravir, emtricitabine, and tenofovir alafenamide tablets)
• Vocabria (cabotegravir tablets for oral use)
• Cimduo (lamivudine and tenofovir disoproxil fumarate tablets, for oral use)
• Tybost (cobicistat tablets)
• Combivir (lamivudine, zidovudine)
• Complera (emtricitabine/rilpivirine/tenofovir disoproxil fumarate tablets)
• Prezista (darunavir)
• Prezcobix (darunavir and cobicistat tablets)
• Symtuza (darunavir, cobicistat, emtricitabine, and tenofovir  alafenamide tablets)
• Delstrigo (doravirine, lamivudine, and tenofovir disoproxil fumarate tablets)
• Descovy (emtricitabine and tenofovir alafenamide tablets)
• Dovato (dolutegravir and lamivudine tablets)
• Juluca (dolutegravir and rilpivirine tablets, for oral use)
• Pifeltro (doravirine tablets)
• Tivicay (doutegravir 50mg tablets)
• Edurant (rilpivirine tablets)
• Sustiva (efavirenz)
• SYMFI (efavirenz, lamivudine and tenofovir disoproxil fumarate)
• Symfi Lo (efavirenz, lamivudine and tenofovir disoproxil fumarate tablets)
• Genvoya (elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide tablets)
• Stribild (elvitegravir, cobicistat, emtricitabine, tenofovir df)
• Emtriva (emtricitabine)
• Truvada (emtricitabine tenofovir df)
• Odefsey (emtricitabine, rilpivirine, and tenofovir alafenamide fixed-dose combination tablets)
• Fuzeon (enfuvirtide)
• Epivir (lamivudine)
• Intelence (etravirine tablets)
• Lexiva (fosamprenavir calcium)
• Rukobia (fostemsavir extended-release tablets)
• Trogarzo (ibalizumab-uiyk injection)
• Invirase (saquinavir mesylate)
• Isentress (raltegravir tablets)
• Kaletra Capsules (lopinavir, ritonavir capsules)
• Kaletra Tablets (lopinavir, ritonavir tablets)
• Sunlenca (lenacapavir tablets and injection)
• Selzentry (maraviroc)
• Viramune (nevirapine)
• Viramune XR (nevirapine extended-release tablets, for oral use)
• Norvir (ritonavir capsules, oral solution)
• Norvir Soft Gelatin Capsules (ritonavir)
• Retrovir (zidovudine)
• Retrovir IV (zidovudine injection)
• Viread (tenofovir disoproxil fumarate)